Could a private equity deal be the end of Walgreens?
The ultimate victor from the deal may be neither the Walgreens executives nor Sycamore, but Walgreens bondholders. It has ...
Will private equity kill Walgreens?
There are plenty of reasons to be skeptical that private equity will help Walgreens get out of turbulent times.
Walgreens to be acquired by private-equity firm for $10 billion
The company will continue to operate under the name Walgreens and its headquarters will remain in the Chicago area.
Walgreens to Be Bought by Private Equity Firm in $10 Billion Deal
Shares of Walgreens Boots Alliance have lost about half their value in the past year, as the chain has faced pressure in its ...
Walgreens Agrees to $10 Billion Acquisition by Private Equity Firm
Walgreens said Thursday that Sycamore will pay $11.45 per share, giving the deal an equity value just under $10 billion.
Walgreens agrees to be acquired by private equity firm Sycamore Partners for nearly $10 billion
Walgreens said Thursday that Sycamore will pay $11.45 per share, giving the deal an equity value just under $10 billion.
Public Broadcasting Service (PBS)9d
Walgreens agrees to acquisition by private equity firm for almost $10 billion
Walgreens Boots Alliance says it has agreed to be acquired by private equity firm Sycamore Partners as the struggling ...
Walgreens agrees to be acquired by private equity firm for almost $10 billion
Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling ...
Crain's Chicago Business8d
Here's what's likely to happen to Walgreens under private equity
Putting its many affairs in order will probably be easier as a private company, but there are still pitfalls — including a ...
Walgreens sold to private equity firm for almost $10 billion
Walgreens said Thursday that Sycamore will pay $11.45 per share, giving the deal an equity value just under $10 billion.
AOL6d
Will private equity kill Walgreens?
Walgreens has been attempting a financial ... and would be sold to Sycamore Partners, a private equity firm. Less than a decade ago it was America’s largest drugstore chain, and its stock ...